Stay updated on TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial
Sign up to get notified when there's something new on the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page.

Latest updates to the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3; no study content changes are indicated.SummaryDifference0.1%

- Check13 days agoChange DetectedThe screenshots indicate only minor UI/layout adjustments; no changes to core study details (eligibility criteria, primary outcomes, or enrollment) are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedCore study details—title, conditions, eligibility, primary outcomes, and locations—appear unchanged; the observed updates are cosmetic/UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedLocations now show additional recruitment sites across the US, Australia, Canada, Israel, Spain, Poland, Portugal, and other regions, with Revision: v3.3.3.SummaryDifference2%

- Check35 days agoChange DetectedThe screenshots show only minor visual/layout differences (e.g., alignment, fonts, spacing) with no changes to core study content such as eligibility criteria, primary/secondary outcomes, locations, or enrollment numbers. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedNo meaningful changes detected between the two versions; the page content and layout appear unchanged.SummaryDifference0.1%

Stay in the know with updates to TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-935 in Pediatric Developmental/Epileptic Encephalopathies Clinical Trial page.